NIH funding Archives
Opioid prescriptions after childbirth linked to increased risk of overdose, persistent use
Jun. 9, 2020—Women who are prescribed opioids after childbirth have an increased risk of persistent opioid use or other serious opioid-related events, including overdose, in their first year postpartum, according to a new study by Vanderbilt University Medical Center researchers. This is true regardless of whether the woman had a vaginal delivery or a cesarean section.
Study finds newborn opioid withdrawal rates show evidence of stabilizing
May. 12, 2020—Rates of neonatal abstinence syndrome (NAS) have plateaued after 20 years of increasing frequency across the country, according to a new study published in Health Affairs. NAS is a withdrawal syndrome experienced by some opioid-exposed newborns after birth.
Center for AIDS Research lands NIH grant renewal
May. 7, 2020—The National Institutes of Health (NIH) has renewed its support of the Tennessee Center for AIDS Research (CFAR), a four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health and Nashville CARES.
New method captures early viral-host protein interactions
May. 7, 2020—Researchers have developed a method to identify the primary interactions between incoming viral RNA genomes and host proteins.
Study reveals an inherited origin of prostate cancer in families
Mar. 23, 2020—Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with family histories of the disease.
Study links neural circuit with impaired social function
Jan. 29, 2020—Stimulating neural activity between the amygdala and the nucleus accumbens — a brain region associated with pleasure — impairs social function even though mice find the stimulation rewarding, a new study published by Vanderbilt researchers reports.
VUMC study sheds light on gastric cancer development
Jan. 16, 2020—VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
VUMC study to use artificial intelligence to explore suicide risk
Jan. 15, 2020—Investigators will use computational methods to shed light on suicidal ideation and its relationship to attempted suicide, predict suicidal ideation and suicide attempt using routine electronic health records (EHRs) and explore the genetic underpinnings of both.
VUMC-led team isolates antibody that blocks bird flu
Dec. 12, 2019—VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans.
Device studied as non-addictive option for chronic pain
Nov. 7, 2019—Vanderbilt researchers are developing a focused ultrasound neuromodulation device as a non-invasive and non-addictive method for treating chronic pain.
Autism study tracks musical rhythm as possible treatment
Nov. 6, 2019—Researchers are partnering to study musical rhythm synchronization as a part of social development and how it’s disrupted in children with autism spectrum disorder (ASD) in hopes of developing music interventions for improving social communication.
VIGH study seeks to expand epilepsy care efforts in Africa
Oct. 10, 2019—The Vanderbilt Institute for Global Health (VIGH), with Aminu Kano Teaching Hospital (AKTH), will conduct a clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers.
